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Two hundred tlfty pediatric «18 years of age) patients underwent orthotopic 
liver transplantation because of end-stage liver dIsease and were given 
combination therapy wllh cyclosporlne and prednisone. The most common 
Indications for transplantallon In decreasIng order of frequency were biliary 
atresia, Inborn errors of metabOlism, and postnecrotlc cirrhosis. The 5·year 
actuarial survival for the enllre group was 69.2%. Age and diagnosis did not 
Influence survival. Infections were the most common cause of death. followed 
by liver failure and cerebrovascular occident. The Impact of retraMplantation 
on survival depends on the Indication. The survival Is better when retransplan· 
tatlon Is carried out after re/ecllon than because of technical complications, 
and the laller has a beller survival Ihan does primary graft nonfuncllon. The 
difference In survival amonglhese groups Is stallstlcally sIgnificant. The quality 
of life for 164 of 173 survivors Is good to excellent; only nine children are currently 
experiencing medical problems. A perslsent problem In pediatriC transplanta· 
tlon Is the scarcity of smoll donors. (J PED1ATR 1987;111{6. part 2):1039-45) 
-" .'. / / !J 
The clinical manifestations of chronic li\'er disease in the 
adult arc usually insidious and slow to progress. In 
contrast, the clinical features of cnd·stage li,er disease in 
children develop over a short time: 2nd are followed by 
devastating results. A t)pical example is tht patient with 
cirrhosis secondary to biliary atrcsia. In these paticnts, 
ja und ice, hypersplenism. and portal h) p<:rlension quickly 
devclop. in addition to the c<Jmplications of m~labIorplion 
5uch as diarrhea. growth retardation, and bone fractures. 
was introduced into clinical practice in 1980.1 The imme-
diate impact of c)'closporine on sur.·ival ..... as so remarkable 
that in a fe .... yeaTS there has been a proliferation of new 
transpbnt ccnters all mer the .... orld. \10reover, the indica-
tions for hepatic replacement arc constantl) op3nding to 
beneflt more patients "'ho other .... isc w(luld incvitably die 
of hepatic failure Eunpubli~hed data). 
Three yca rs ago, ort hotopic liver tr a n~pla nta tion left the 
realm of c:r.rcrimental surgcry and became an accepted 
mode of therapy for patients .... ith irrevcrsible liver dis· 
easel The first human liver transplant .... as performed in 8 
child 23 years ago, but progress was slow until c)'closporine 
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We reporl the results in the first 250 pediatric paticnts 
"'ho receivcd liver transplants during the eFclo~porine 
era. 
METHODS 
From March I, 1980, to June 30, 1986, 250 children (of 
665 li\'cr recipicnts) under .... ent hepatic repbcement for 
advanced liver di~ea~cK The charts of these 250 patients 
.... erc revic .... ed. and the follo\\ing data recorded: age. sex. 
indications for primary transplants, indications for rctrans-
plantation. and survival. Causes of death \\cre also 
rc\'ic"cd, as "cll as dominant clinical featurcs of liver 
disease before trampbnt:!tion. 
Thc techniques of hanesting and of li\er replacement 
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Fig. 1. Indications for hepatic transplantation in 250 pediatric patients treated" ilh cFcgo~porine and prednisone 
combined. 
Tobie I. Clinical features in 250 pediatric patients 
bdore liver transplantation 
Exlrohepoflc Other 
blllory atresia Indlc allons 
<Of.) <Of.> 
A~cites 68 75 
Bone disease 82 41 
Bilia r)' sepsis 55 .. 
Variceal hemorrhage 29 33 
[nccrha lopal hy 13 30 
Spont;)ncous bJcterial 5 II 
peritonitis 
have: been published in detail c1~cvKhereKD Many of the 
patients had previous abdominal operations, such as por-
tocnteroqomies Eha~ai procedure:s) in those: v. ith biliary 
atre~iaI or e:xplor2tory lar3rotomies for diagnostic pur-
po,es Matching was done mainly by si7e and blood t)pe, 
ahh()u[h some p:lIients re(eiled or[:lns from donors in 
ddferent blood groups.' )\;0 attempt "as made: to match 
human leukocyte antigen (HLA) loci preoperatively. 
qmmuno~llprrEDy~ionK Patients used to receive a dose of 
c)closporine orally a fe ..... hours before surgery, but this 
practice has been abJndoned. At pre~entK cyclo'porine is 
begun during the operation at a dose of 2 mg/kg intrave-
nously. The s:Jme do~e is repeated paSloperatildy elery 8 
hours until olal feedings arc resumed. Oral C)closl"1rine is 
then begun at a dose of \7.5 mg/kg/d, divided in two 
doses. Intran:nously administered cFc1o~pvrine is subse-
quentl) reduce~ if adequate In'els are maintained b) the 
oral route. s Cyclosporine dosage is adjusted according to 
the concentration of the drug in whole blood as determined 
by high-pressure liquid chroamtography or by radioimmu-
noassay. RIA is used more frequently' in our practice. The 
dosage is also adjuqed based on symptoms and renal 
function. because the toxicity of the drug docs not al ..... ays 
correlate with the blood level. Steroids arc also started 
during the operation. A dose of 500 mg prednisolone: is 
givcn intral'enously soon after the allograft liver is revas-
cularized. If the: patient'S clinical condition is relatilel), 
good, a S·da)' course of prednisolone is gilen. beginning 
..... ith 100 mg the first day poqopcratilely, and tapering b)' 
20 mg daily and cnding v.ith a mJintcnance do~c of 10 mg 
daily. further reductions of the steroid doses arc made on 
an indil'idual basis. In the presence of rejection, patients 
are: given h)drocortisone: intravenously. If no rc~pvnse is 
ob~enedI the: 5·day course of steroids is repeated.' Addi· 
tional adjulant therapy h:ls con,isted of pol)clonal anti· 
lymphocyte globulin in the: heginning of the ~eries and 
monoclonal antibody (OKT t 3 Orlhoclone:, Ortho Pharma-
ceutical Corporation, Raritan, N.J.) recently. The: most 
common indication for OKT t 3 therap)' has been steroid· 
resistant rejection.')n a fe ..... patients "ith btent rejection, 
10 ..... dmcs of alathioprine have been added 10 the cFc1o~po· 
rine·steroid regimen. 
Stathlic21 analF~isK Patient surlil'al W:lS c:llclilattd by 
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Fig. 2. Actuarial survival (lire table method) in 250 pediatric patients compared \II ith that in 415 adult patients during 
cFDc1o~porine era. DiffcrcnC( not statistically significant. 
RESULTS 
Indicalions for li\er Iransplanlalion. The: indications for 
hepatic replacement are: shown in Fig. I. There were I IS 
male: and 135 female palienls, with mean age 5.9 ± 4.92 
(SO) years (range 4 months to 18 years). Almost all 
patients had ad\'2nced li\'er disease, except for an occasion-
al patient who had received a transplant for hepatic 
malignancy and had li'cr function that \las normal or close 
to normal. 
Biliary a(rfSia. The biliary atretic s)ndromc was by far 
the most common indication for liver tramplantation. In 
this group, the majority (84<;;) of patients had e:\trahepatic 
biliary atresia, and the rest had biliary h)J"-1plasia, which 
in some cases was part of Alagillc s)ndrome, 
Almoq all of the patients with bili.H) atresia had 
undergone a biliary drainage procedure (K2sai), and in 
sc\eral p3tients the hepatectomy was difficult because of 
adhesions formed after many prC\ious llbdomir.al opera-
tions, 
The domin?nt clinical fe:lturc:s in patients \Ioith extrahe-
patic atresia are shown in Table I and are comp:ued with 
those in other !i\er tramplant recirients who \Ioere operated 
on because of diagnoses other than extrahepatic atresia. 
The incidence of \ariccaJ bleeding and a~cites \10 as similar 
in the,e t\\O groups of patients; ho\\C\er, cholangitis was a 
significant problem in pJtients with e\trahcp.1tic biliary 
atresia and was the cause of numerous ho'pitali73tions. 
Bone di~e:lsc was also seen more frequently in p~tients \10 ith 
Eytrahcp~tic biliary alresia. Encephalopathy was ob~cryDed 
Tobie II. Dominant clinical features in patients with 
ol,antitrypsin deficiency before liver tramplantation 
n ... 
Ascites 23 80 
Variceal hemorrhage 17 59 
Jaundice 11 38 
Ence pha lora t hy 3 10 
less often in patients Voith extrahepatic biliary atresia, 
because the other group included patients who had 
received tran~plants because of acute hepatic failure sec-
ondary to v'iral hcpatitis or Wilson di~easeK 
Inborn urors. Inborn errors of metabolism were the 
second most common indication for hepatic transplanta-
tion; Crl·antitrypin deficient) \10 as the most common diag-
nosis in this group. T\Ioent)'·nine of the O~l pediatric 
patients under\llcnt hepatic tramplantation because of 
ol,antitrypsin deficiency. The phenotype was ZZ in 22 
patients, MZ in t\\O, SZ in two, and was unknown in three 
patients. The diagnosis of OJ-antitrypsin deficienc), was 
made between 1 month and 6 years, with initial symptoms 
of jaundice in 23 patients, ascites in three patients, and 
gastrointestinal hemorrhage in three patients. By the lime 
of trampl:Jntation, 17 (58.6o/c) of 29 patients "ith Cl I-
antitr)psin deficiency h~d experienced "ariceal hemor-
rhare, and the grcat m:ljority had ascites (Table II). Of the 
29 pJticnts, si\ required retramplantation. The indications 
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Fig. 3. Actuarial survival Iccarding to age aroup in 250 pediatric liver tran~p!ant recipients. Note that age has not 
influenced long· term sun'in!thus far. Difference not statistically significant. 
one, and thrombosis of the \'Cna ca\'a and portal vein in one 
patient. Of these siJ., three ~ith hepatic artery thrombosis 
died after retransplantation. 
Five of the 29 patients ~ith QI'antitr)psin deficiency 
died. Of the 24 sun'i\'ors, three patients have slightly 
abnormal liver function secondar)' to chronic rejection, and 
may eventually require retramplantation. Another patient 
has immunosuppression·induced I) mphoproliferati\'e dis· 
ease, Another patient v.ho had QI·antitr)psin deficiency 
and biliary atresia has an ind\<dling percutaneous biliary 
catheter because of an ischemic obstruction of the bile 
ducts, This patient had thrombosis of the hepatic arlery 
poqopcrati\ely. T .... ent) of the 24 allend school; the other 
four are not of school age, but arc gro",ing v.ell. 
Other metabolic disorders treated .... ith hepatic trans· 
plantation were t) rminrmia, Wilson di~easeI gl)cogen 
storage dj~CDaseI and familial h) pcrcholc>tcrolemia. 
Less frequent indications .... cre con£enital heratic fibro-
sis, familial <:holestasis, p0;tnecrotic cirrhosis, secondary 
biliar)' cirrhosis, ncon3t31 hepatitis, and malignancy. 
Suni\sl. The o\erall actu:;rial survi\'al in rediatric 
p;'ltients is 69.29C al 5 years, .... hich is significantl) beller 
when compared ~ith a hi~torical group giHn azathioprine 
(23%). Comparcd .... ith that in adults, the sun'i\'al is 
identical up to 2 )ears; the difference in adult sun'i\'31 after 
2 years is not statistically significant (Fig, 2), Ovcrthe last 
2 years there has been an increase in the number of hepatic 
tramrlants in infants. The actu"rial sun'ival in these small 
children ~as not statisticall) different from that in older 
patients (Fig. 3); hov.ner, the rostorerati\e course in 
many of these infants was mailed by comrli~alionsK" 
Influencr of diagnosis on sunh.1. There is very little 
difference in survival according to the diagnostic indica· 
tions for hepatic replacement (Fig. 4), Most of the deaths 
occur within the first 6 months after transplantation, and 
the allrition is minimal after I year. The S')'ear actuarial 
survival is TTKU~ for patients with postnecrotic cirrhosis 
(n - 27), T9KO~ for patients with inborn errors of the 
metabolism (n .. 53), and 66.lo/c for patients with biliary 
atretic s)ndrome (n .. 127). 
The principal causes of death in 61 consecuti\'c children 
who died at the Uni\ersity of Piltsburgh, in decrcasing 
order of frequency, .... ere infection (22 patients, 36%) 
hepatic necrosis (12 patients. 20O/C), central nen'ous system 
complications (eight patients, 139C), and intraabdominal 
hemorrhage (sc\en patients, 11'k), T .... clve other patients 
died of misccllaneous cau~es such as respiratory distress 
syndrome, m)ocardial infarction, I) mrhoproliferati\'c dis· 
case, recurrent hepatoma, and multis)qem organ failure 
(Table III), Bacterial infections .... crc seen slightl) more 
often than fungal infections. Deaths caused by \iral 
infectiom .... cre rare and <xcurred late. C)\'S complications 
consisted of cerebrovascular accident, frequently associat· 
ed v.ith h)pcrtensi\'e crisis or coagulopathy or both. Fatal 
intraabdominal hemorrhage .... as the c~use of death in 
seven patients. Four of these patients h3d ruptured mycotic 
aneur)'sms, and another patient had a fungal infection 
involving the portal Hin. Two other patients had sC\cre 
coagulopathy secondar) to liver failure. 
R.lran'planlalion. The indications for rctran~pbntation 
in 67 EOS~F of the 250 patients studied were technical 
complications in 29 (43,3'r..) patients, rejection in 29 
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FIg .•. Actuarial survival based on dla~nostie indications for hepatic transplantation in 250 pediatric patients, 
Difference among several groups not stali~licallF ~i~niElcantK 
(43.3<;;). and primary graft nonfunction in nine E1PK4~F 
(Fig_ 5). Technical complications arc seen more frequently 
in children than in adults; hepatic artery thrombosis 
accounts for nearly all technical problems requiring 
ret ra nsplantation. 
The difference in sun'ival after retransplantation for the 
foregoing three indications is highly significant. Patients 
requiring a second transplant bccau~e: of primary graft 
nonfunction had the poorest survi\al (approximately 10% 
at I year), but actuarial sun'ival increased to 48'h at 4 
years ",hen the indication was a technical complication. 
and to 79C;{ at 4 years when the reason for retransplanta-
tion was rejection. 
Qualit) of life. Of the: 173 suni\ors, only nine pJtients 
are currently experiencing major medical probkms. Two 
of these pJtients ha\'e biliary strictures secondary to 
thrombosis of the hepatic artery, and con<.equent mild 
hepJtic dysfunction. Two other p~tientsK "ho had trans· 
plants before I ycar of age. have ind\\elling biliary 
catheters because of necrosis of the major bik ducts after 
thrombosis of the hepatic artery, Unlikc the previous two 
p.lticnts, the hepatic function in thC<.e t\\O pJticnts is 
occllen\. Three ratient~ have ongoing chronic rcje(tion 
and \\ ill require retraosplantation. One p.1ticnt "ho under· 
",cnt simultaneous liver and kidney tran'plantation 
bCC:1r~C of cFDqino~is undergoes hCl11odial)sis for chronic 
renal failure; he has normal li\er function. Laq, a 7· 
year·old child with normal hepatic function has intraab· 
domin:d 1)'lIl'hoprolifcrati\'c diycKl~eI Thi\ r.}tient recently 
under\,cnt a dd)ulking procedure and is free of ~Fl1irtomsI 
Tobie III. Principal causes of death in 61 children who 
survived at least 24 hours after hepatic replacement 
n "to 
Infection 22 36 
Liver failure 12 20 
eNS complications S 13 
mo~toperalivt hemorrhage 7 II 
Respirator)' di,trcss 5) ndrome 2 3 
M)ocardial infarction 2 3 
Other S 13 
ahhough he 5tiJ1 has residual tumor; his condition is stable, 
and immuno,uppression therapy has been stopped entirely. 
The remaining patients live normal lives and have near-
normal gro"th and development. Eight (28'/() of 29 
patients crossed percentiles in nn upward direction and 
"'ere above the: 5th percentile:, Thirteen patients "'ere 
belo\\ the 5th percentile before and after ~urgcrFD; of the~eI 
10 h3\'e normal po"th \elocit)', Only fOllr (14':;) p:lticnls 
had a reduction in gro\\th to belo" the 5th percentile. Four 
(14o/c) other pJtients "'ho "t:re nornnlly gro\\n before 
hepatic replacement continued to grow normally after 
~urgerFDK Thirteen of these 29 pJticnts h3d biliary atresiaK~b 
DISCUSSION 
Thc indications for liver transpbnLltion ha\c expanded 
since cyclosporine \\3S introduced into clinical practice in 
1980. O'er a short pnic)(i of time, a rcmarh.lblc improve-
ment in suni\'JI "'35 obscl\ed in p;lticlltS treah:d \\ ith a 
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FIg. 5. Actuarial survi\'al of 67 pediatric patients "'ho lo~t fir~t ,raft. based on indication ror rctran~rlanlPtionK 
combination of CFDclo~rorine and prednisone, in contrast to 
those given a combination of a7athioprine and prednisone 
in earlier series.2 
When liver tran;plantation was first performed in the 
1960s, a frequent indication for hepatic replacement was 
malignancy, because those patients had no chance for 
survival otherwise. Howe\·er. many other patients" ho 
would benefit from Ih'er transplantation were not consid· 
ered because of the opcrimcntal nature of the operation. 
Based on the much improved rcsults .... ith c)closporine. 
liver transplantation became an acccpted therapy for 
patients "jth adl'aneed hepatic di~ease in the 19f.0s.1.' Age 
limitations are not as relclant as they "ere before e)clo-
sporine Eunpubli~hed data). t-.:oncthc1ess, a significant 
problem in pediatric liler transplantation continues to be 
the scarcity of small pcdi;lIric donors. 
The arpropriate: time for tran~planlation i~ .... hen the 
palient begins to ~holl signs of hepatic dccompcn'3tion. In 
children, 5ubtlc signs arc fatigue. failure to grow, and 
deereJscd activity bel. liver transrbntation should not 
be d.:1J)cd until manifeQ;llions of end~stage lilcr di~ease 
de\ elor. such as \arieeal bleeding or encerhalopathy. 
Althl)ugh it has becn difficult to predict II hich rJtients "ill 
do lIell 2fter transplantation,' it is logical to think that 
paticnt~" ho still hal'c some resen'c would fare better after 
hepatic transrbntation than patients \\ith terminJI qages 
of the dise3se such as hcp:llorenal S} ndrome:. 
rrom the \iel\point of stat is Ii cal significance. the under· 
I) ing disc3sc docs not influence the (lutcomc. Cirrhosis 
~ccond:lqy to biliary 3tresiil, hep:lIitis, 1l"3ntitr)r,in defi· 
ciency, and Wilson disease is a c1ear·cut indication for 
hepatic replacement. T)Tosinemia, on the other hand, is an 
inborn error of mc:taboli~m associated with a high inei· 
dence of hepatoma. These patients should undergo hepatic 
replacement before malignancy occurs. Likewise, other 
metabolic disorders that hal'e their origin in the li\er, such 
as gl}eogen storage disease. hemochromatosis. and possi-
bly hemophilia. are treated more frequently" ith liver 
transplantation. The presence of mJlignaney is not an 
ab~olute contraindication, although the risk of recurrence 
exists. In a previous invcstigation, patients" ho had inci· 
dent~1 neoplasms in the liler and underllenl trgn~pbnta· 
tion for other rea~ons h;l\e sho"n no clidcnce of recur· 
rence thus far.' 
Most of the deaths in pediatric li\er transpl;;ntation 
occur within the first 6 months. Infe.:tions arc the most 
common cause of death. and the l)PC of infection laries 
according to the time of omct after tran'pbntJtion and the 
precipitating cau~eK Early infections arc USUJII) bacterial 
or fungal and arc precipitated by complic~tions related to 
the operation, such as arh:rial thTllIl1b-.."is, bile k.1h. or 
intestinal perforations. Viral complications arc ~een late, 
and u~ually fol1o\\ unlli~e therapy for rejection. 
The majority of the children will ha\'e an alm05t normal 
life c\ecpt for the need of medication. This is a ~r1fall price, 
con~idcring that dLath \\(luld be their fate 1\ ithout liver 
tran~plantationK The m:ljorit) of th<"<,e children gro\\ nor· 
m:llly after hepatic repbcemcnt and arc able to attend 
~Ehool and pJrticipJte in daily aClilities. 
Patients "ith primMY graft nonfunction dl,teriorate 
a.'oJ,.,." III 
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rapidly, and retransplantation is urlent. Thrombosis of the 
hepatic .rtery may lead to regional necrosis of the liver and 
abscess formatIOn. Althoul!h a few patients have survived 
without arterial supply, these patients should also underl!o 
retran~plantation immediatelF·KD~ Retransplantatlon be-
cause of rejection is associated with the best survival, 
probably because these patients are usually free of infec-
tion and arc in better condition than those with primary 
graft nonfunction or thrombosis of the hepatic artery. 
Retransplantation has played an important role in improve 
ing survival." 
We conclude that liver transplantation is the treatment 
of choice for several conditions leading to end-stage liver 
disease. The most important problem in pediatric Jiver 
transplantation is the una\'ailability of small pediatric 
donors. 
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